Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001680329-25-000004

Director sold 15,705 shares at $59.50 ($934,448)

  • Director acquired 10,837 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Reeve Emma · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-11 Sale : show line 1 in the form 10b5-1 −3,534 $59.50 $210,273 11,666 D
2025-09-11 Sale : show line 2 in the form 10b5-1 −1,334 $59.50 $79,373 10,332 D
2025-09-11 Exercise or conversion : show line 3 in the form 10b5-1 +10,000 $25.69 $256,900 20,332 D
2025-09-11 Sale : show line 4 in the form 10b5-1 −10,000 $59.50 $595,000 10,332 D
2025-09-11 Exercise or conversion : show line 5 in the form 10b5-1 +837 $33.63 $28,148 11,169 D
2025-09-11 Sale : show line 6 in the form 10b5-1 −837 $59.50 $49,802 10,332 D
Open-market sales · 15,705 sh · avg $59.50 · $934,448

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-09-11 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −10,000 0 D
2025-09-11 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −837 0 D
Loading xslF345X05/form4-09162025_050903.xml…